Jorge Eduardo Cortes

Director

  • Source: Scopus
  • Calculated based on no. of publications stored in Pure and citations from Scopus
1989 …2021

Research activity per year

If you made any changes in Pure these will be visible here soon.

Network

Hagop M. Kantarjian

  • University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • MDACC
  • Department of Biostatistics
  • University of Dundee
  • Medical Breast Service
  • University of Texas at Austin
  • Merck
  • Department of Bioimmunotherapy
  • Novartis Pharmaceuticals
  • Rambam Health Care Campus Israel
  • Leukemia
  • Division of Stem Cell Transplantation and Cellular Therapy
  • Fudan University
  • Children's Memorial Hospital
  • Johnson & Johnson
  • Singapore General Hospital
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Daiichi Pharmaceutical Corporation
  • St. Vincent's Hospital Melbourne
  • National Institutes of Health
  • Investigational Drug Branch
  • Icahn School of Medicine at Mount Sinai
  • Department of Lymphoma and Myeloma
  • Department of Leukemia
  • Novartis
  • Department of Leukemia
  • The University of Texas M. D. Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Susan O'brien

  • MDACC
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of California at Irvine
  • University of Dundee
  • Merck
  • Department of Bioimmunotherapy
  • Novartis Pharmaceuticals
  • Goethe University Frankfurt
  • Leukemia
  • University of Texas at Austin
  • Children's Memorial Hospital
  • Singapore General Hospital
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • MD Anderson Cancer Center
  • Novartis
  • The University of Texas M. D. Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Farhad Ravandi

  • University of Texas MD Anderson Cancer Center
  • MDACC
  • Department of Leukemia
  • University of Dundee
  • Department of Bioimmunotherapy
  • University of Texas at Austin
  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Illinois at Chicago
  • Department of Leukemia
  • Department of Leukemia
  • The University of Texas M. D. Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Guillermo Garcia-Manero

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • MDACC
  • University of Dundee
  • Novartis Pharmaceuticals
  • Johnson & Johnson
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Daiichi Pharmaceutical Corporation
  • National Institutes of Health
  • Investigational Drug Branch
  • Novartis
  • The University of Texas M. D. Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Elias Jabbour

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas at Austin
  • Division of Stem Cell Transplantation and Cellular Therapy
  • Fudan University
  • University of California at Irvine
  • University of Texas Health Science Center at Houston

External person

Francis J. Giles

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at San Antonio
  • Department of Infectious Diseases
  • Department of Leukemia
  • Trinity College Dublin
  • Merck
  • Department of Bioimmunotherapy
  • Novartis Pharmaceuticals
  • University of Texas at San Antonio
  • Goethe University Frankfurt
  • Leukemia
  • National University of Ireland, Galway
  • University of Texas Health Science Center
  • GlaxcoSmithKline
  • Children's Memorial Hospital
  • Northwestern Medicine Developmental Therapeutics Institute
  • Johnson & Johnson
  • Singapore General Hospital
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Daiichi Pharmaceutical Corporation
  • Department of Leukemia
  • National Institutes of Health
  • Investigational Drug Branch
  • HRB Clinical Research Facility
  • Novartis
  • University of Texas Health Science Center at Houston

External person

Gautam Borthakur

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston
  • Division of Stem Cell Transplantation and Cellular Therapy

External person

S. Pierce

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • MDACC
  • Leukemia
  • Children's Memorial Hospital
  • University of Texas at Austin
  • University of Washington
  • Singapore General Hospital
  • St. Vincent's Hospital Melbourne
  • University of Texas Health Science Center at Houston

External person

Srdan Verstovsek

  • University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • St. Vincent's Hospital Melbourne
  • University of Texas Health Science Center at Houston

External person

Stefan Faderl

  • Rutgers - The State University of New Jersey, Newark
  • University of Medicine and Dentistry of New Jersey
  • MDACC
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Bioimmunotherapy
  • University of Dundee
  • Merck
  • Novartis Pharmaceuticals
  • University of Texas at Austin
  • Johnson & Johnson
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Daiichi Pharmaceutical Corporation
  • John Theurer Cancer Center
  • Jazz Pharmaceuticals
  • Novartis
  • The University of Texas M. D. Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

D. Thomas

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Novartis Pharmaceuticals
  • University of Texas at Austin
  • Johnson & Johnson
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Daiichi Pharmaceutical Corporation
  • St. Vincent's Hospital Melbourne
  • Department of Leukemia
  • Department of Bioimmunotherapy
  • Novartis
  • University of Texas Health Science Center at Houston

External person

Tapan Kadia

  • MDACC
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Marina Konopleva

  • University of Texas MD Anderson Cancer Center
  • Division of Stem Cell Transplantation and Cellular Therapy
  • Department of Leukemia
  • Sect. of Molec. Hematology/Therapy
  • Department of Leukemia
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Naval Daver

  • MDACC
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Leukemia
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Z. Estrov

  • University of Texas MD Anderson Cancer Center
  • Department of Bioimmunotherapy
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Alfonso Quintás-Cardama

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Novartis
  • University of Texas Health Science Center at Houston

External person

Moshe Talpaz

  • Comprehensive Cancer Center
  • University of Michigan, Ann Arbor
  • University of Texas MD Anderson Cancer Center
  • Life Sciences Institute, Division of Hematology-Oncology, University of Michigan
  • Department of Internal Medicine
  • Department of Bioimmunotherapy
  • Merck
  • Novartis Pharmaceuticals
  • Department of Leukemia
  • Life Sciences Institute
  • MD Anderson Cancer Center
  • Department of Experimental Therapeutics
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Michigan Medical Center
  • Novartis
  • Department of Internal Medicine
  • Comprehensive Cancer Center
  • University of Texas Health Science Center at Houston

External person

William Wierda

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Naveen Pemmaraju

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Michael J. Keating

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Children's Memorial Hospital
  • University of Texas at Austin
  • Singapore General Hospital
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • St. Vincent's Hospital Melbourne
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Elihu E. Estey

  • University of Washington
  • Department of Medicine
  • University of Texas MD Anderson Cancer Center
  • Department of Infectious Diseases
  • Department of Leukemia
  • Leukemia
  • Fred Hutchinson Cancer Research Center
  • Clinical Research Division
  • GlaxcoSmithKline
  • University of Texas at Austin
  • Department of Medicine
  • Johnson & Johnson
  • Singapore General Hospital
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • National Institutes of Health
  • Investigational Drug Branch
  • University of Texas Health Science Center at Houston

External person

Michael Andreeff

  • University of Texas MD Anderson Cancer Center
  • Division of Stem Cell Transplantation and Cellular Therapy
  • Department of Leukemia
  • Leukemia
  • Sect. of Molec. Hematology/Therapy
  • Children's Memorial Hospital
  • Singapore General Hospital
  • University of Texas Health Science Center at Houston

External person

Alessandra Ferrajoli

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

C. Dinardo

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Mary Beth Rios

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Novartis Pharmaceuticals
  • Novartis
  • University of Texas Health Science Center at Houston

External person

Carlos E. Bueso-Ramos

  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology and Molecular Diagnostics
  • Department of Leukemia
  • University of Texas at Austin
  • Department of Pathology
  • University of Texas Health Science Center at Houston

External person

Keyur P. Patel

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Hematopathology and Molecular Diagnostics
  • Department of Hematopathology
  • Department of Leukemia
  • University of Texas MD Anderson Cancer Center, Department of Pathology, Unit 085
  • University of Texas Health Science Center at Houston

External person

Charles Koller

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Department of Leukemia
  • University of Texas at Austin
  • Children's Memorial Hospital
  • Singapore General Hospital
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Maher Albitar

  • University of Texas MD Anderson Cancer Center
  • M.D. Anderson Cancer Center
  • Division of Laboratory Medicine
  • Quest Diagnostics Incorporated
  • Department of Leukemia
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Pathology
  • Departments of Oncology/Hematopathology and Research and Development
  • Quest Diagnostics
  • Department of Biostatistics
  • Johnson & Johnson
  • Laboratory Medicine
  • Novartis Pharmaceuticals
  • NeoGenomics Laboratories
  • Novartis
  • University of Texas Health Science Center at Houston

External person

Jianqin Shan

  • University of Texas MD Anderson Cancer Center
  • Merck
  • Department of Bioimmunotherapy
  • Department of Leukemia
  • Novartis Pharmaceuticals
  • Novartis
  • University of Texas Health Science Center at Houston

External person

Steven M. Kornblau

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Division of Stem Cell Transplantation and Cellular Therapy
  • Dan L. Duncan Cancer Center
  • Baylor College of Medicine
  • Singapore General Hospital
  • University of Texas at Austin
  • National Institutes of Health
  • Investigational Drug Branch
  • University of Texas Health Science Center at Houston

External person

Miloslav Beran

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Department of Leukemia
  • University of Texas at Austin
  • Children's Memorial Hospital
  • Singapore General Hospital
  • University of Texas Health Science Center at Houston

External person

Koji Sasaki

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Tokyo Medical and Dental University
  • University of Texas Health Science Center at Houston

External person

Andreas Hochhaus

  • Friedrich Schiller University Jena
  • Heidelberg University 
  • Univeristate Heidelberg
  • Universitätsklinikum Jena
  • Universitaetsklinikum Jena
  • Universitätstsklinikum Jena

External person

Nitin Jain

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Raja Luthra

  • University of Texas MD Anderson Cancer Center
  • Department of Pathology
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Kyoto University
  • University of Texas Health Science Center at Houston

External person

Nicholas J. Short

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Xuelin Huang

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Department of Leukemia
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Koichi Takahashi

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Kyoto University
  • Institute ForAppliedCancer Science, Department of Genomic Medicine, University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Richard E. Champlin

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Case Western Reserve University
  • University of Texas Health Science Center at Houston

External person

Dan Jones

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Hematopathology
  • Quest Diagnostics Incorporated
  • University of Texas Health Science Center at Houston

External person

J. A. Burger

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Leukemia
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

T. Manshouri

  • M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Division of Laboratory Medicine
  • Department of Leukemia
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Michele Baccarani

  • University of Bologna

External person

Jeffrey L. Jorgensen

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Hematopathology and Molecular Diagnostics
  • Department of Leukemia
  • Department of Biostatistics
  • University of Texas MD Anderson Cancer Center, Department of Pathology, Unit 085
  • University of Texas Health Science Center at Houston

External person

Preetesh Jain

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Division of Cancer Medicine
  • Division of Clinical and Translational Sciences
  • University of Texas Health Science Center at Houston

External person

E. J. Freireich

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Children's Memorial Hospital
  • University of Texas at Austin
  • University of Texas Health Science Center at Houston

External person

Timothy Hughes

  • South Australian Health And Medical Research Institute
  • Institute of Medical and Veterinary Science Australia
  • University of Adelaide
  • Centre for Cancer Biology
  • Royal Adelaide Hospital
  • School of Medicine
  • SA Pathology
  • Division of Hematology

External person

Mark Brandt

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

L. Jeffrey Medeiros

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Pathology
  • University of Texas Health Science Center at Houston

External person

Hanna Jean Khoury

  • Emory University
  • Clark Atlanta University
  • Department of Hematology and Medical Oncology Winship
  • Department of Hematology and Medical Oncology, Emory University School of Medicine
  • Department of Hematology and Medical Oncology
  • School of Medicine
  • Department of Hematology and Oncology

External person

Jerald P. Radich

  • Fred Hutchinson Cancer Research Center
  • Clinical Research Division
  • University of Washington
  • Newcastle University
  • Frederick Hutchinson Cancer Research Center

External person

Marcos de Lima

  • Case Western Reserve University
  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Yesid Alvarado

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Rebecca Garris

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Carlo Gambacorti-Passerini

  • University of Milan - Bicocca
  • Azienda Ospedaliera San Gerardo Monza
  • McGill University

External person

Dong Wook Kim

  • Seoul St. Mary's Hospital
  • Seoul St. Mary's Hospital
  • Seoul St. Mary's Hospital
  • Catholic University of Korea
  • St. Mary's Hospital
  • St. Mary's Hospital
  • Seoul St. Mary's Hospital

External person

Michael W. Deininger

  • University of Utah
  • Huntsman Cancer Institute
  • Division of Hematology and Hematologic Malignancies
  • Department of Internal Medicine
  • Oregon Health and Science University
  • Department of Oncological Sciences
  • Division of Hematology and Medical Oncology
  • Knight Cancer Institute

External person

Michael J. Mauro

  • Medical College of Wisconsin
  • Oregon Health and Science University
  • Memorial Sloan-Kettering Cancer Center
  • Knight Cancer Institute

External person

Xuemei Wang

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Biostatistics Department and
  • University of Texas Health Science Center at Houston

External person

Partow Kebriaei

  • University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas Health Science Center at Houston

External person

Giuseppe Saglio

  • University of Turin
  • Azienda Ospedaliera S. Luigi Gonzaga
  • European Group for Blood and Marrow Transplantation
  • Orbassano University Hospital
  • Department of Clinical and Biological Sciences

External person

Maro Ohanian

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Kiran Naqvi

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Ghayas C. Issa

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Sa A. Wang

  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Harbin Medical University
  • University of Texas Health Science Center at Houston

External person

François Guilhot

  • CHU de Poitiers
  • Université de Poitiers
  • University Miletrie Hospital
  • Institut national de la santé et de la recherche médicale

External person

Giovanni Martinelli

  • University of Bologna
  • IRCCS Istituto scientifico romagnolo per lo studio e la cura dei tumori - Meldola (FC)
  • L. e A. Seragnoli Institute of Hematology

External person

J. Lipton

  • Canterbury District Health Board
  • University of Toronto
  • Medical College of Wisconsin
  • University Health Network
  • Department of Medical Oncology and Hematology
  • Princess Margaret Hospital
  • Ontario Cancer Institute University of Toronto

External person

Rashmi Kanagal-Shamanna

  • Department of Hematopathology and Molecular Diagnostics
  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Hematopathology
  • University of Texas Health Science Center at Houston

External person

Graciela M. Nogueras-González

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Richard A. Larson

  • Medical College of Wisconsin
  • The University of Chicago
  • Department of Medicine
  • Department of Medicine

External person

Joseph D. Khoury

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • Department of Leukemia

External person

Brian J. Druker

  • Oregon Health and Science University
  • Division of Hematology and Medical Oncology
  • Howard Hughes Medical Institute
  • Knight Cancer Institute
  • Newcastle University

External person

Jane F. Apperley

  • Imperial College London
  • Imperial College Healthcare NHS Trust
  • Department of Haematology
  • European Group for Blood and Marrow Transplantation
  • Hammersmith Hospital

External person

Prithviraj Bose

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Musa Yilmaz

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Hematology and Oncology
  • Baylor College of Medicine
  • University of Texas Health Science Center at Houston

External person

Tim H. Brümmendorf

  • RWTH Aachen University
  • University Medical Center Hamburg-Eppendorf

External person

Jean Pierre Issa

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Temple University
  • Johns Hopkins University
  • University of Texas Health Science Center at Houston

External person

Cameron C. Yin

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Lynne Abruzzo

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • College of Medicine
  • Ohio State University
  • University of Texas Health Science Center at Houston

External person

Sergio Giralt

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • Memorial Sloan-Kettering Cancer Center
  • Department of Medicine, Memorial Sloan Kettering Cancer Center
  • Hematology Service
  • University of Texas Health Science Center at Houston

External person

Philipp le Coutre

  • Charité – Universitätsmedizin Berlin
  • Humboldt University of Berlin

External person

Prajwal Boddu

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Varsha Gandhi

  • University of Texas MD Anderson Cancer Center
  • Department of Experimental Therapeutics
  • MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Aziz Nazha

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Cleveland Clinic Foundation
  • Department of Hematologic Oncology and Blood Disorders
  • University of Texas at Austin
  • University of Texas Health Science Center at Houston

External person

Lucia Masarova

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Franck E. Nicolini

  • Hospices civils de Lyon
  • Hôpital Édouard Herriot
  • Hematology Department 1G
  • SociétéFrançaise de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
  • European Group for Blood and Marrow Transplantation
  • French Group of CML (Fi-LMC Group)
  • Universite Claude Bernard Lyon 1
  • Institut national de la santé et de la recherche médicale
  • National Institutes of Health, Bethesda
  • National Institutes of Health
  • Centre Léon Bérard

External person

Charles Chuah

  • Singapore General Hospital
  • Graduate Medical School
  • National University of Singapore
  • Cancer and Stem Cell Biology Program
  • Duke
  • Duke-National University of Singapore Graduate Medical School

External person

William Plunkett

  • University of Texas MD Anderson Cancer Center
  • Department of Experimental Therapeutics
  • University of Dundee
  • Department of Leukemia
  • MD Anderson Cancer Center
  • The University of Texas M. D. Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Razelle Kurzrock

  • University of Texas MD Anderson Cancer Center
  • Medical Breast Service
  • Department of Bioimmunotherapy
  • Rambam Health Care Campus Israel
  • Department of Leukemia
  • Unit 422
  • University of California at San Diego
  • Johnson & Johnson
  • University of Texas Health Science Center at Houston

External person

Apostolia Tsimberidou

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Ayalew Tefferi

  • Mayo Clinic College of Medicine and Science
  • Mayo Clinic Rochester, MN
  • Department of Internal Medicine
  • Division of Hematology
  • Divisions of Cardiovascular Diseases and Pediatric Cardiology, Departments of Medicine, Pediatrics, and Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic
  • Department of Hematology
  • Division of Gastroenterology and Hepatology

External person

Fabio P.S. Santos

  • University of Texas MD Anderson Cancer Center
  • Hospital Israelita Albert Einstein
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Mark Levis

  • Johns Hopkins University
  • Department of Oncology
  • Oncology Department
  • Sidney Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins University

External person

Sergej Konoplev

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Kapil N. Bhalla

  • Medical College of Georgia
  • Cancer Center
  • Baylor College of Medicine
  • Georgia Health Sciences University
  • University of Kansas
  • Georgia Prevention Center
  • Department of Medicine
  • Department of Medicine
  • Houston Methodist Hospital
  • Cancer Center
  • Department of Medicine
  • Augusta University
  • University of Kansas
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of South Florida
  • The University of Kansas
  • University of Texas Health Science Center at Houston

External person

Michael Rytting

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Pediatrics
  • University of Texas Health Science Center at Houston

External person

Sima Jeha

  • University of Texas MD Anderson Cancer Center
  • Novartis Pharmaceuticals
  • Daiichi Pharmaceutical Corporation
  • Department of Pediatrics
  • St. Jude Children Research Hospital
  • Department of Bioimmunotherapy
  • Novartis
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

J. Pinilla-Ibarz

  • H. Lee Moffitt Cancer Center
  • University of South Florida
  • Immunology Program

External person

Kate J. Newberry

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

O. G. Ottmann

  • Cardiff University
  • Department of Haematology
  • Goethe University Frankfurt
  • Novartis Pharmaceuticals
  • Goethe Universität Frankfurt Am Main

External person

Sanam Loghavi

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center, Department of Pathology, Unit 085
  • University of Texas Health Science Center at Houston

External person

Richard M. Stone

  • Dana-Farber Cancer Institute
  • Department of Medical Oncology, Dana-Farber Cancer Institute
  • Harvard University
  • Department of Medical Oncology
  • Dana-Farber/Harvard Cancer Center

External person

Christopher B. Benton

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Uday Popat

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Dong Wook Kim

  • Catholic University of Korea
  • Department of Internal Medicine
  • Catholic Hematopoietic Stem Cell Bank

External person

S. Lerner

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Guillermo Montalban-Bravo

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Meir Wetzler

  • Leukemia Section
  • Roswell Park Cancer Institute
  • Novartis Pharmaceuticals Corporation
  • Novartis

External person

John Goldman

  • Hammersmith Hospital
  • Imperial College London
  • National Institutes of Health

External person

Sara Dellasala

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

François Xavier Mahon

  • CHU de Bordeaux
  • Centre Georges-François Leclerc
  • Institut national de la santé et de la recherche médicale
  • Groupe hospitalier Pellegrin
  • Hôpital Cardiologique du Haut-Lévêque
  • French Group of CML (Fi-LMC Group)
  • Université de Bordeaux
  • CNRS
  • Université de Bordeaux
  • Université Victor Segelen

External person

Shimin Hu

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Neil P. Shah

  • University of California at San Francisco
  • Department of Medicine
  • Department of Medicine, University of California-San Francisco

External person

Daniel J. DeAngelo

  • Harvard University
  • Department of Medical Oncology
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Department of Medical Oncology, Dana-Farber Cancer Institute
  • Dana

External person

Marylou Cardenas-Turanzas

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Martin S. Tallman

  • Memorial Sloan-Kettering Cancer Center
  • Department of Medicine, Memorial Sloan Kettering Cancer Center
  • Robert H. Lurie Compreh. Cancer Ctr.
  • Northwestern University

External person

Gloria N. Mattiuzzi

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Wei Wang

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

S. Goldberg

  • John Theurer Cancer Center, Hackensack University Medical Center
  • Rutgers - The State University of New Jersey, Newark

External person

Richard T. Maziarz

  • Oregon Health Sciences University
  • Oregon Health and Science University

External person

B. Nebiyou Bekele

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Neil P. Shah

  • University of California at San Francisco
  • University College of Los Angeles
  • University of California at Los Angeles
  • UCLA School of Medicine

External person

Jenny Shan

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Paolo Strati

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Rita Assi

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Lebanese American University
  • Gilbert and Rose-Marie Chagoury School of Medicine

External person

Jeffrey E. Lancet

  • University of South Florida
  • Immunology Program

External person

Patricia Ault

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Susan Branford

  • Institute of Medical and Veterinary Science Australia
  • University of South Australia
  • Centre for Cancer Biology
  • University of Adelaide
  • School of Medicine
  • Genetics and Molecular Pathology

External person

Philip Thompson

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Constantine S. Tam

  • University of Texas MD Anderson Cancer Center
  • University of Melbourne
  • Peter Maccallum Cancer Centre
  • St. Vincent's Hospital Melbourne
  • University of Texas Health Science Center at Houston

External person

Matt Kalaycio

  • Cleveland Clinic Foundation
  • Dept. of Hematol. and Med. Oncology
  • Department of Hematology/Medical Oncology
  • Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic
  • Department of Hematology and Oncology

External person

Wei Qiao

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Terry L. Smith

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Children's Memorial Hospital
  • University of Texas Health Science Center at Houston

External person

Ralph Arlinghaus

  • University of Texas MD Anderson Cancer Center
  • Novartis Pharmaceuticals
  • Novartis
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Lianchun Xiao

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Martin C. Müller

  • Heidelberg University 
  • Institute for Hematology and Oncology

External person

Mark Litzow

  • Department of Internal Medicine
  • Mayo Clinic Rochester, MN
  • Mayo Clinic College of Medicine and Science
  • Department of Internal Medicine
  • Department of Hematology

External person

Mary M. Horowitz

  • Medical College of Wisconsin
  • Center for International Blood and Marrow Transplant Research
  • Center for International Blood and Marrow Transplant Research
  • TOPS Obesity and Metabolic Research Center
  • Center for International Blood and Marrow Transplant Research

External person

Jing Ning

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Ricardo Pasquini

  • Universidade Federal do Paraná
  • Hospital de Clínicas de Curitiba

External person

Gail J. Roboz

  • Cornell University
  • Division of Hematology and Oncology
  • Department of Medicine, Weill Cornell Medical College, New York Presbyterian Hospital
  • New York Presbyterian Hospital

External person

E. Ritchie

  • Cornell University
  • Weill Cornell Medical College of Cornell University

External person

Wael Saber

  • Medical College of Wisconsin
  • TOPS Obesity and Metabolic Research Center
  • Center for International Blood and Marrow Transplant Research
  • Center for International Blood and Marrow Transplant Research

External person

Charles Schiffer

  • Wayne State University

External person

Robert Peter Gale

  • IAVI Human Immunology Laboratory
  • Imperial College London
  • Center for Advanced Studies in Leukemia
  • Celgene Corporation

External person

Issa Khouri

  • University of Texas MD Anderson Cancer Center
  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas Health Science Center at Houston

External person

H. Yang

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Rüdiger Hehlmann

  • Heidelberg University 
  • ELN Foundation

External person

Richard Silver

  • Cornell University
  • New York Presbyterian Hospital
  • Scripps Clinic

External person

Dushyant Verma

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Teresa McQueen

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas Health Science Center at Houston

External person

Elisabetta Abruzzese

  • University of Rome Tor Vergata
  • ASL Roma 2

External person

Francisco Cervantes

  • University of Barcelona
  • August Pi i Sunyer Biomedical Research Institute

External person

Abhishek Maiti

  • Department of Internal Medicine
  • University of Texas Health Science Center at Houston
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Simona Soverini

  • University of Bologna

External person

Yang Huh

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Children's Memorial Hospital
  • University of Texas Health Science Center at Houston

External person

Hong Mu

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Betul Oran

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Hervé Dombret

  • Université Paris 7
  • Université de Paris

External person

Guilin Tang

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Ruben A. Mesa

  • Mayo Clinic Scottsdale, AZ
  • Division of Hematology and Medical Oncology
  • University of Texas Health Science Center

External person

Adam Craig

  • A Wholly Owned Subsidiary of Teva Branded Pharmaceutical Products RandD, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Cephalon, Inc.
  • Sunesis Pharmaceuticals

External person

Mary Ann Richie

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Ronald Paquette

  • UCLA Division of Hematology/Oncology
  • University of California at Los Angeles
  • UCLA School of Medicine
  • Department of Medicine
  • Cedars-Sinai Medical Center

External person

Kim Anh Do

  • University of Texas MD Anderson Cancer Center
  • Biostatistics Department and
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Luke Akard

  • Indiana Blood and Marrow Transplantation
  • St. Francis Hospital and Health Centers
  • Indiana Blood and Marrow Transplantation
  • Indiana Blood and Marrow Transplantation St. Francis Franciscan Alliance

External person

Kimberly Hayes

  • University of Texas MD Anderson Cancer Center
  • University of Texas at Austin
  • Singapore General Hospital
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Duncan H. Mak

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Ehab Atallah

  • Division of Hematology and Oncology
  • Medical College of Wisconsin
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Pau Montesinos

  • Hospital Universitario La Fe
  • Instituto de Salud Carlos III
  • Centro de Investigación Biomédica en Red

External person

Philippe Rousselot

  • Université Paris-Saclay
  • ComUE Paris-Saclay
  • Université Paris 7
  • Université Versailles Saint-Quentin-en-Yvelines Paris-Saclay U1173

External person

Baldeep Wirk

  • Stony Brook University
  • Seattle Cancer Care Alliance
  • University of Florida
  • Department of Internal Medicine

External person

Elizabeth J. Shpall

  • University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Division of Stem Cell Transplantation and Cellular Therapy
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Celalettin Ustun

  • University of Minnesota Twin Cities
  • Augusta University
  • Division of Hematology
  • Department of Medicine
  • Department of Medicine
  • Department of Internal Medicine
  • East Carolina University
  • Division of Hematology Oncology and Transplantation
  • Section of Hematology/Oncology
  • Department of Medicine
  • Division of Hematology-Oncology and Transplantation
  • Rush University

External person

Lingsha Zhou

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • St. Vincent's Hospital Melbourne
  • University of Texas Health Science Center at Houston

External person

Xian Zhou

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Donna Hogge

  • Leukemia/Bone Marrow Transplant Program of British Columbia
  • University of British Columbia

External person

M. H. Qazilbash

  • University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Division of Stem Cell Transplantation and Cellular Therapy
  • Case Western Reserve University
  • University of Texas Health Science Center at Houston

External person

Talha Badar

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Zhihong Zeng

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Gabriela Rondon

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Gary J. Schiller

  • University of California at Los Angeles

External person

David Marks

  • National Health Service
  • University Hospitals Bristol and Weston NHS Foundation Trust
  • University of Bristol
  • Bristol Adult BMT Unit

External person

Gianantonio Rosti

  • University of Bologna
  • Institute of Hematology and Medical Oncology Seràgnoli

External person

Carol Bivins

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Alexander E. Perl

  • University of Pennsylvania

External person

John Wright

  • National Institutes of Health
  • Cancer Therapy Evaluation Program
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Stefan E. Ciurea

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Mahmoud D. Aljurf

  • King Faisal Specialist Hospital and Research Centre

External person

Bing Z. Carter

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Monica Kwari

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • National Institutes of Health
  • Investigational Drug Branch
  • University of Texas Health Science Center at Houston

External person

Frank G. Haluska

  • ARIAD Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company Limited

External person

Borje S. Andersson

  • University of Texas MD Anderson Cancer Center
  • Division of Stem Cell Transplantation and Cellular Therapy

External person

Jean Yves Cahn

  • University Hospital Grenoble
  • Université de Franche-Comté
  • Universite Joseph Fourier

External person

Animesh D. Pardanani

  • Mayo Clinic Rochester, MN
  • Mayo Clinic College of Medicine and Science
  • Department of Internal Medicine
  • Divisions of Cardiovascular Diseases and Pediatric Cardiology, Departments of Medicine, Pediatrics, and Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic
  • Department of Hematology

External person

Rammurti T. Kamble

  • Baylor College of Medicine

External person

Michael J. Keating

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Pei Lin

  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center

External person

Iman Jilani

  • Quest Diagnostics Incorporated
  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center

External person

Carmen Fava

  • University of Texas MD Anderson Cancer Center
  • University of Turin
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

C. Hosing

  • University of Texas MD Anderson Cancer Center
  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas Health Science Center at Houston

External person

Edward Copelan

  • Carolinas Health Care System
  • Cleveland Clinic Foundation
  • Carolinas Healthcare System Reproductive Medicine and Infertility
  • Levine Cancer Institute
  • Carolinas HealthCare System

External person

Geoffrey Chan

  • Pfizer Oncology
  • Pfizer

External person

Amber Fullmer

  • University of Texas at Austin
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

John F. DiPersio

  • Washington University St. Louis
  • Division of Medical Oncology
  • Department of Medicine

External person

Bipin N. Savani

  • Vanderbilt University
  • Division of Nephrology

External person

David A. Rizzieri

  • Duke University

External person

Hady Ghanem

  • Lebanese American University
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Delphine Rea

  • Université Paris 7

External person

Mukta Arora

  • Center for International Blood and Marrow Transplant Research
  • University of Minnesota Twin Cities
  • Division of Hematology-Oncology and Transplantation

External person

Dietger Niederwieser

  • Leipzig University

External person

Eric Feldman

  • Cornell University

External person

Deborah Mccue

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Peter F. Thall

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

M. Michallet

  • Hôpital Édouard Herriot
  • Hematology Department 1G
  • SociétéFrançaise de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
  • European Group for Blood and Marrow Transplantation
  • French Group of CML (Fi-LMC Group)
  • Hospices civils de Lyon

External person

D. Kontoyiannis

  • MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Infectious Diseases
  • Department of Infectious Diseases
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Paul Manley

  • Univeristate Heidelberg
  • Novartis
  • Novartis Pharmaceuticals

External person

George Q. Daley

  • Harvard University
  • Nephrology Division
  • D630, Division of Pediatric Hematology/Oncology
  • Whitehead Institute for Biomedical Research

External person

Mansour Alfayez

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Graciela Nogueras Gonzalez

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Department of Leukemia
  • Departments of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Geoffrey L. Uy

  • Washington University St. Louis
  • Department of Medicine

External person

Stephen A. Strickland

  • Vanderbilt University
  • Department of Medicine

External person

Mark Routbort

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Laurie Letvak

  • University of Texas MD Anderson Cancer Center
  • Novartis Pharmaceuticals
  • Novartis Pharmaceuticals Corporation
  • Novartis Pharmaceuticals
  • Novartis
  • Department of Leukemia

External person

Jiří Mayer

  • Masaryk University

External person

Victor M. Rivera

  • ARIAD Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company Limited

External person

Jonathan E. Kolitz

  • Institute
  • Northwell Health System
  • Hofstra University
  • North Shore-Long Island Jewish Health System

External person

Norbert Vey

  • Aix-Marseille Université
  • University of Texas at Austin
  • University of Texas MD Anderson Cancer Center
  • Singapore General Hospital
  • University of Texas Health Science Center at Houston
  • Institut Paoli Calmettes

External person

Issam Raad

  • M. D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Infectious Diseases
  • Department of Infectious Diseases
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Feng Wang

  • University of Texas MD Anderson Cancer Center
  • Institute ForAppliedCancer Science, Department of Genomic Medicine, University of Texas MD Anderson Cancer Center

External person

Peter P. Ruvolo

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Internal Medicine
  • University of Texas Medical Branch at Galveston
  • University of Texas Health Science Center at Houston

External person

N. Hamerschlak

  • Hospital Israelita Albert Einstein
  • Centro de Hematologia de

External person

B. Douglas Smith

  • Sidney Kimmel Cancer Center at Johns Hopkins
  • Johns Hopkins University
  • Department of Oncology
  • Sidney Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins University

External person

F. Cabanillas

  • University of Texas MD Anderson Cancer Center
  • Auxilio Cancer Center
  • Department of Lymphoma and Myeloma
  • University of Texas Health Science Center at Houston

External person

Robert K. Stuart

  • Division of Hematology/Oncology, Department of Medicine, Medical University of South Carolina
  • Medical University of South Carolina
  • Hollings Cancer Center

External person

Jianhua Zhang

  • University of Texas MD Anderson Cancer Center
  • National Institutes of Health
  • University of Texas Health Science Center at Houston

External person

Wei Zhang

  • Baylor College of Medicine
  • Molecular Physiology and Biophysics
  • Emory University
  • Department of Pediatrics, Emory University School of Medicine
  • Department of Stomatology, Tongji Hospital, Huazhong University of Science and Technology
  • Huazhong University of Science and Technology
  • Tongji Hospital, Huazhong University of Science and Technology
  • Medical College of Georgia
  • Department of Medicine
  • Wuhu No.2 People’s Hospital
  • Department of Endocrinology and Metabolism
  • Wuhu No.2 People’s Hospital
  • Central South University
  • Department of Nephrology
  • Department of Cellular Biology and Anatomy
  • Case Western Reserve University
  • National Institutes of Health
  • Cancer Genome Atlas Program Office, National Cancer Institute at NIH, Bldg. 31
  • Department of Biochemistry; and Environmental Health Sciences
  • Department of Biochemistry
  • Nanchang University
  • Albany Medical College
  • Center for Cardiovascular Sciences
  • Department of Respiratory Medicine
  • University of Georgia
  • Department of Foods and Nutrition
  • University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center, Department of Pathology, Unit 085
  • Department of Cancer Biology and Center for Genomics and Personalized Medicine Research
  • Wake Forest University
  • Harvard University
  • College of Animal Science and Technology
  • Nanjing Agricultural University
  • Division of Stem Cell Transplantation and Cellular Therapy
  • Department of Leukemia

External person

Michael R. Grunwald

  • Carolinas Health Care System
  • Carolinas Healthcare System Reproductive Medicine and Infertility
  • Johns Hopkins University
  • Levine Cancer Institute
  • Levine Cancer Institute/Atrium Health
  • Carolinas HealthCare System
  • Levine Cancer Institute

External person

Jason Gotlib

  • Stanford University
  • Department of Medicine
  • Department of Medicine (Hematology)

External person

Edwin P. Alyea

  • Dana-Farber Cancer Institute
  • Department of Medical Oncology, Dana-Farber Cancer Institute

External person

Julianne Chen

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Vivian Oehler

  • Fred Hutchinson Cancer Research Center
  • Clinical Research Division

External person

Hsiang Chun Chen

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

W. Ma

  • Quest Diagnostics Incorporated

External person

Fabrizio Pane

  • University of Naples Federico II

External person

Gregory A. Hale

  • Johns Hopkins University
  • Johns Hopkins All Children’s Hospital

External person

Ian D. Lewis

  • Royal Adelaide Hospital
  • Royal Adelaïde Hôpital/South Australia Pathology

External person

Ahmed Aribi

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Eduardo Olavarria

  • Hospital Virgen del Camino
  • Imperial College Healthcare NHS Trust
  • Catherine Lewis Center
  • Hammersmith Hospital

External person

Carmino A. De Souza

  • Universidade Estadual de Campinas
  • Hematology and Hemotherapy Center

External person

Y. Chen

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Lymphoma and Myeloma
  • University of Texas Health Science Center at Houston

External person

T. Fischer

  • Otto von Guericke University Magdeburg
  • Johannes Gutenberg University Mainz
  • Harvard University

External person

Michael S. Mathisen

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Kiyomi Morita

  • The University of Tokyo
  • University of Texas MD Anderson Cancer Center

External person

Wendy Schober

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Division of Stem Cell Transplantation and Cellular Therapy

External person

S. Wen

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Yoshihiro Inamoto

  • Fred Hutchinson Cancer Research Center
  • National Cancer Center Hospital
  • Division of Clinical Research
  • Clinical Research Division

External person

Tessa L. Holyoake

  • University of Glasgow
  • College of Medical, Veterinary and Life Sciences
  • Glasgow Royal Infirmary

External person

Zi Chen

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Fudan University
  • University of Texas Health Science Center at Houston

External person

Jeff Szer

  • Royal Melbourne Hospital

External person

M. A. Sekeres

  • Cleveland Clinic Foundation
  • University of Miami

External person

Michael Heuser

  • Hannover Medical School

External person

David S. Sanford

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of British Columbia
  • University of Texas Health Science Center at Houston

External person

Juan Luis Steegmann

  • Hospital Universitario de la Princesa

External person

Luis Fayad

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Lymphoma and Myeloma
  • University of Texas Health Science Center at Houston

External person

James M. Foran

  • Mayo Clinic Jacksonville, FL
  • University of Alabama at Birmingham
  • BirminghamComprehensive Cancer Center

External person

Min Du

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Xiaochun Zhu

  • TOPS Obesity and Metabolic Research Center
  • Medical College of Wisconsin
  • Center for International Blood and Marrow Transplant Research
  • Center for International Blood and Marrow Transplant Research

External person

Armand Glassman

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Bioimmunotherapy
  • University of Texas at Austin
  • University of Texas Health Science Center at Houston

External person

Jacob M. Rowe

  • Rambam Health Care Campus Israel
  • University of Texas MD Anderson Cancer Center
  • Shaare Zedek Medical Center
  • Northwestern University

External person

Sarit Assouline

  • McGill University
  • Jewish General Hospital

External person

Vivian R. Ruvolo

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Division of Stem Cell Transplantation and Cellular Therapy

External person

Aref Al-Kali

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Hematology
  • Mayo Clinic Rochester, MN
  • University of Texas Health Science Center at Houston

External person

A. Megan Cornelison

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas Health Science Center at Houston

External person

Alan List

  • University of South Florida
  • University of Arizona

External person

Guy Gammon

  • Daiichi Sankyo Pharma Development
  • Ambit Biosciences
  • Inc.
  • Daiichi Sankyo Company, Limited

External person

Jeffrey Skinner

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Guido Marcucci

  • OHIO STATE UNIVERSITY
  • Ohio State University
  • Wexner Medical Center
  • Department of Internal Medicine, Division of Hematology, Ohio State University
  • Department of Molecular Virology, Immunology and Medical Genetics
  • Division of Human Cancer Genetics

External person

Y. Shou

  • Department of Oncology
  • Novartis USA
  • Novartis Pharmaceuticals
  • Novartis

External person

David Marin

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • Imperial College Healthcare NHS Trust
  • Imperial College London
  • Hammersmith Hospital

External person

Andrew Wei

  • Monash University
  • Alfred Hospital

External person

Chul S. Ha

  • University of Texas MD Anderson Cancer Center
  • Children's Memorial Hospital
  • Department of Radiation Oncology
  • University of Texas Health Science Center at Houston

External person

Rajesh R. Singh

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Richard A. Van Etten

  • University of California at Irvine

External person

Harry P. Erba

  • University of Alabama at Birmingham
  • UAB Comprehensive Cancer Center
  • Division of Hematology and Oncology

External person

Kwang Woo Ahn

  • Medical College of Wisconsin
  • Division of Biostatistics
  • TOPS Obesity and Metabolic Research Center
  • Center for International Blood and Marrow Transplant Research

External person

Curtis E. Gumbs

  • Duke University
  • Duke University
  • Center for Human Genome Variation
  • University of Texas MD Anderson Cancer Center
  • Institute ForAppliedCancer Science, Department of Genomic Medicine, University of Texas MD Anderson Cancer Center

External person

Margaret Dugan

  • Univeristate Heidelberg
  • Novartis
  • Novartis Pharmaceuticals Corporation
  • Novartis Pharmaceuticals

External person

Frederick R. Appelbaum

  • Fred Hutchinson Cancer Research Center
  • University of Washington
  • Clinical Research Division

External person

Carlos Romo

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Zhuang Zuo

  • Medical College of Georgia
  • Department of Physiology and Endocrinology, Medical College of Georgia
  • Augusta University
  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Anna Turkina

  • Russian Academy of Medical Sciences

External person

Annie Claude Benichou

  • A Wholly Owned Subsidiary of Teva Branded Pharmaceutical Products RandD, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Cephalon, Inc.
  • Stragen Services SAS

External person

Edmund K. Waller

  • Emory University
  • Hematology and Oncology Department
  • Department of Hematology and Oncology
  • Division of Cardiology
  • School of Medicine
  • Department of Hematology and Medical Oncology, Emory University School of Medicine
  • Department of Hematology and Medical Oncology

External person

Mitchell Sabloff

  • University of Ottawa
  • Department of Medicine

External person

Tariq Mughal

  • University of Texas Southwestern Medical Center
  • Tufts University

External person

Philipp Erben

  • Heidelberg University 

External person

Ricardo H. Alvarez

  • University of Texas MD Anderson Cancer Center
  • Division of Clinical and Translational Sciences
  • University of Texas Health Science Center at Houston
  • Cancer Treatment Centers of America

External person

M. Hamadani

  • West Virginia University
  • Osborn Hematopoietic Malignancy and Transplantation Program
  • Department of Medicine
  • Osborn Hematopoietic Malignancy and Transplantation Program
  • Medical College of Wisconsin
  • TOPS Obesity and Metabolic Research Center

External person

C. Zhu

  • Bristol-Myers Squibb

External person

Manisha Mone

  • Novartis Pharmaceuticals Corporation
  • Novartis Pharmaceuticals
  • Novartis

External person

Yu Shen

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Anna M. Eiring

  • Department of Molecular Virology, Immunology and Medical Genetics
  • Ohio State University
  • University of Utah
  • Huntsman Cancer Institute
  • Human Cancer Genetics Program

External person

Bruce D. Cheson

  • National Institutes of Health
  • Medicine Branch
  • University of Texas MD Anderson Cancer Center
  • Georgetown University

External person

Christian Recher

  • Université Paul Sabatier Toulouse III
  • Hôpital Purpan
  • CHU de Toulouse

External person

Ann Woolfrey

  • Fred Hutchinson Cancer Research Center
  • Cleveland Clinic Foundation

External person

M. Brigid Bradley-Garelik

  • Bristol-Myers Squibb

External person

Vikas Gupta

  • University Health Network
  • University of Toronto
  • Princess Margaret Hospital
  • Ontario Cancer Institute University of Toronto

External person

B. Simonsson

  • Uppsala University

External person

Christopher A. Eide

  • Oregon Health and Science University
  • Howard Hughes Medical Institute
  • Division of Hematology and Medical Oncology

External person

Zimu Gong

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • AMITA Health St Joseph Hospital
  • University of Texas Health Science Center at Houston

External person

Stephanie Lustgarten

  • ARIAD Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company Limited

External person

Daniel A. Pollyea

  • University of Colorado Denver
  • University of Colorado Anschutz Medical Campus

External person

Timothy Clackson

  • ARIAD Pharmaceuticals, Inc.

External person

Richard E. Clark

  • Royal Liverpool and Broadgreen University Hospitals NHS Trust
  • Department of Molecular and Clinical Cancer Medicine
  • University of Liverpool
  • Liverpool University Hospitals NHS Foundation Trust

External person

Martha Wadleigh

  • Medical College of Wisconsin
  • Dana-Farber Cancer Institute
  • Department of Medical Oncology, Dana-Farber Cancer Institute

External person

S. G. O'Brien

  • Newcastle University
  • Newcastle upon Tyne Hospitals NHS Foundation Trust
  • Royal Victoria Infirmary

External person

B. S. Dabaja

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas at Austin
  • Department of Radiation Oncology
  • University of Texas Health Science Center at Houston

External person

Delphine Rea

  • Université Paris 7

External person

K. Yee

  • Princess Margaret Cancer Centre
  • University Health Network
  • University of Texas MD Anderson Cancer Center
  • Vion Pharmaceuticals Inc.
  • Ontario Cancer Institute University of Toronto
  • Princess Margaret Hospital

External person

Steven Coutre

  • Stanford University
  • Division of Otolaryngology/Head and Neck Surgery

External person

Weidong Wendy Ma

  • Pfizer Oncology
  • Pfizer

External person

Uri Rozovski

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Tel Aviv University
  • University of Texas Health Science Center at Houston

External person

Brian Bolwell

  • Cleveland Clinic Foundation
  • Department of Hematology and Oncology

External person

Juliana M. Benito

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

R. Bhatia

  • City of Hope National Med Center
  • Cincinnati Children's Hospital Medical Center
  • Medical Center
  • University of Alabama at Birmingham
  • Division of Hematology and Oncology

External person

Samer Khaled

  • City of Hope National Med Center
  • City of Hope

External person

Dale Bixby

  • University of Michigan, Ann Arbor
  • Life Sciences Institute, Division of Hematology-Oncology, University of Michigan

External person

Jessica K. Altman

  • Robert H. Lurie Compreh. Cancer Ctr.
  • Northwestern University
  • Department of Medicine

External person

R. Z. Orlowski

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Lymphoma and Myeloma
  • University of Texas Health Science Center at Houston

External person

Ravin J. Garg

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Anthony Murgo

  • University of Texas MD Anderson Cancer Center
  • National Institutes of Health
  • Division of Cancer Treatment and Diagnosis
  • Investigational Drug Branch
  • University of Texas Health Science Center at Houston

External person

Luciano J. Costa

  • University of Alabama at Birmingham
  • Medical University of South Carolina
  • Division of Hematology/Oncology, Department of Medicine, Medical University of South Carolina

External person

Kelly A. Soltysiak

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Mona Lisa Alattar

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas at Dallas
  • University of Texas Health Science Center at Houston

External person

Hartmut Döhner

  • Ulm University
  • Department of Internal Medicine III

External person

Debra Resta

  • University of Texas MD Anderson Cancer Center
  • Novartis Pharmaceuticals Corporation
  • Novartis Pharmaceuticals
  • Novartis
  • University of Texas Health Science Center at Houston

External person

Francesco Onida

  • Matarelli Foundation for Blood Diseases
  • IRCCS Fondazione Ca'Granda – Ospedale Maggiore Policlinico - Milano
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Maria R. Khouri

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

P. Y. Mak

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Susanne Saussele

  • Heidelberg University 

External person

Ken H. Young

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Alireza Eghtedar

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Mirjana Zeremski

  • Pfizer Oncology
  • Pfizer

External person

Fredrick Hagemeister

  • University of Texas MD Anderson Cancer Center
  • Department of Lymphoma and Myeloma
  • University of Texas Health Science Center at Houston

External person

Christopher D. Turner

  • ARIAD Pharmaceuticals, Inc.

External person

N. J. Gallagher

  • Department of Oncology
  • Novartis

External person

Jack W. Hsu

  • University of Florida
  • Department of Medicine

External person

Anjali S. Advani

  • Cleveland Clinic Foundation
  • Dana-Farber Cancer Institute
  • Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic

External person

Eunice S. Wang

  • Roswell Park Cancer Institute
  • Immunology
  • Department of Medicine

External person

Sean M. Post

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Steven Z. Pavletic

  • National Institutes of Health
  • Experimental Transplantation and Immunology
  • National Institutes of Health
  • Experimental Immunology and Transplantation Branch
  • Lab. of Tumor Immunology and Biology
  • Center for Cancer Research
  • National Institutes of Health, Bethesda

External person

Arnon Nagler

  • Sheba Medical Center at Tel Hashomer

External person

Simon Durrant

  • Royal Brisbane and Women's Hospital

External person

Nicholas C.P. Cross

  • Imperial College London
  • Imperial College Healthcare NHS Trust
  • Wessex Regional Genetics Laboratory
  • University of Southampton
  • Hammersmith Hospital

External person

Thomas O'Hare

  • Oregon Health and Science University
  • Division of Hematology and Medical Oncology
  • University of Utah
  • Division of Hematology and Hematologic Malignancies
  • Huntsman Cancer Institute
  • Knight Cancer Institute

External person

Susie Mallard

  • University of Texas MD Anderson Cancer Center

External person

Arturo Vega-Ruiz

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Philippe Schafhausen

  • University Medical Center Hamburg-Eppendorf

External person

Megan Breeden

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Alois Gratwohl

  • University of Basel

External person

Cristina Papayannidis

  • University of Bologna

External person

Ashleigh O'Connell

  • Pfizer Oncology

External person

Eric Bleickardt

  • Bristol-Myers Squibb

External person

Roberto M. Nussenzveig

  • University of Texas MD Anderson Cancer Center
  • University of Utah
  • University of Texas Health Science Center at Houston

External person

Juliana E. Hidalgo

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center

External person

P. Andrew Futreal

  • Wellcome Sanger Institute
  • University of Texas MD Anderson Cancer Center
  • Institute ForAppliedCancer Science, Department of Genomic Medicine, University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Tara L. Lin

  • University of Kansas

External person

Walter Fiedler

  • University Medical Center Hamburg-Eppendorf

External person

N. Gattermann

  • Heinrich Heine University Düsseldorf

External person

Leila Alland

  • Univeristate Heidelberg
  • Novartis

External person

Alice Lynn

  • University of Texas MD Anderson Cancer Center
  • St. Vincent's Hospital Melbourne

External person

Shilpa Paul

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Katja Karjalainen

  • University of Texas MD Anderson Cancer Center
  • University of Helsinki
  • MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Kwang Woo Ahn

  • Medical College of Wisconsin

External person

Harry C. Schouten

  • Maastricht University

External person

Qaiser Bashir

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Gabriel Etienne

  • Centre Georges-François Leclerc
  • French Group of CML (Fi-LMC Group)
  • Centre Léon Bérard

External person

Erkki Koivunen

  • University of Texas MD Anderson Cancer Center
  • University of Helsinki
  • Department of Leukemia

External person

Wadih Arap

  • University of Texas MD Anderson Cancer Center
  • University of New Mexico
  • Department of Internal Medicine
  • University of Texas Health Science Center at Houston

External person

Sangbum Choi

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Department of Internal Medicine
  • University of Texas Health Science Center at Houston
  • Department of Leukemia

External person

Nigel Russell

  • Nottingham University Hospitals NHS Trust

External person

Y. Wei

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Efrosyni Apostolidou

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

James P. Allison

  • Memorial Sloan-Kettering Cancer Center
  • Howard Hughes Medical Institute
  • Department of Immunology
  • University of Texas MD Anderson Cancer Center
  • University of California at Berkeley
  • Immunology Program and Department of Medicine
  • Department of Immunology
  • Immunol. Prog. and Dept. of Medicine
  • Howard Hughes Medical Institute
  • Howard Hughes Medical Institute
  • University of Texas Health Science Center at Houston

External person

John M. Pagel

  • Swedish Medical Center
  • Fred Hutchinson Cancer Research Center
  • University of Washington

External person

Arthur C. Louie

  • Jazz Pharmaceuticals
  • Celator Pharmaceuticals, Inc.

External person

Roberto N. Miranda

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

J. Q. Guo

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Renata Pasqualini

  • University of Texas MD Anderson Cancer Center
  • University of New Mexico
  • Department of Internal Medicine
  • University of Texas Health Science Center at Houston

External person

Inge H. Dufva

  • University of Copenhagen

External person

Keith W. Pratz

  • Johns Hopkins University
  • Department of Oncology
  • Sidney Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins University

External person

Amin Alousi

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center

External person

Ann Cahill

  • Vion Pharmaceuticals Inc.

External person

Zhen Huan Hu

  • Medical College of Wisconsin

External person

Wendy Stock

  • The University of Chicago

External person

John T. Manning

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

James D. Griffin

  • Dana-Farber Cancer Institute
  • Division of Hematologic Malignancies
  • Dana Farber Cancer Center

External person

Amit Lahoti

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Mario Sznol

  • National Institutes of Health
  • Pathology and Ultrastructural Oncology Section
  • Public Health Service contract
  • Clinical Research Branch, Biological Response Modifiers Program
  • Cancer Treatment Evaluation Program
  • National Cancer Institute-Frederick Cancer Research
  • NCI-FCRDC
  • Vion Pharmaceuticals Inc.

External person

Carolina Pavlovsky

  • Angelica Ocampo Hospitalization and Clinical Research Center

External person

Ronan T. Swords

  • University of Miami

External person

Denise Trone

  • Independent Consultant
  • Daiichi Sankyo Pharma Development
  • Ambit Biosciences
  • Daiichi Sankyo Company, Limited

External person

P. H. Wiernik

  • Yeshiva University
  • Cancer Research Foundation of New York
  • Cancer Research Foundation

External person

A. H. Sarris

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Hygeia Hospital
  • Department of Lymphoma and Myeloma
  • University of Texas Health Science Center at Houston

External person

James Gajewski

  • Department of Hematology
  • Oregon Health and Science University
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Tillmann Krahnke

  • Novartis
  • Novartis Pharmaceuticals

External person

Zach Bohannan

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Matjaz Sever

  • University of Texas MD Anderson Cancer Center
  • University of Ljubljana
  • University of Texas Health Science Center at Houston

External person

Ronald M. Sobecks

  • Cleveland Clinic Foundation
  • Department of Hematology/Medical Oncology
  • Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic

External person

Tamas Masszi

  • Szent Laszlo Hospital

External person

N. J. Donato

  • University of Texas MD Anderson Cancer Center
  • MD Anderson Cancer Center
  • Department of Experimental Therapeutics
  • University of Michigan, Ann Arbor
  • Life Sciences Institute

External person

Arnaud Pigneux

  • Université de Bordeaux
  • Haut-Lévêque
  • Hôpital Cardiologique du Haut-Lévêque

External person

S. Pilât

  • University of Texas MD Anderson Cancer Center
  • Department of Bioimmunotherapy
  • University of Texas Health Science Center at Houston

External person

Joseph O. Moore

  • Duke University

External person

R. Digumarti

  • Nizam Institute of Medical Sciences
  • Nizam's Institute of Medical Sciences

External person

Mahran Shoukier

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Lina Han

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Harbin Medical University
  • University of Texas Health Science Center at Houston

External person

Sara S. Strom

  • University of Texas MD Anderson Cancer Center
  • Department of Epidemiology
  • Department of Epidemiology
  • Department of Epidemiology
  • University of Texas Health Science Center at Houston

External person

Yasmin Abaza

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Nianxiang Zhang

  • University of Texas MD Anderson Cancer Center
  • Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Yi Hua Qiu

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Iman Abou Dalle

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Hesham Mohamed

  • Bristol-Myers Squibb

External person

D. G. Gilliland

  • Harvard University
  • Department of Medicine
  • Howard Hughes Medical Institute
  • Dana-Farber Cancer Institute

External person

J. Prchal

  • University of Alabama
  • University of Utah
  • Department of Medicine, University of Alabama at Birmingham
  • University of Alabama at Birmingham
  • Medical College of Georgia
  • Department of Cell and Molecular Biology
  • Hematology Division
  • Hematology Division
  • School of Medicine
  • Augusta University
  • Charles University

External person

Zhi Xiang Shen

  • Shanghai Jiao Tong University

External person

Latasha Little

  • University of Texas MD Anderson Cancer Center
  • Institute ForAppliedCancer Science, Department of Genomic Medicine, University of Texas MD Anderson Cancer Center

External person

Mercedes Gorre

  • Quest Diagnostics Incorporated

External person

Paolo Neviani

  • Department of Molecular Virology, Immunology and Medical Genetics
  • Ohio State University
  • Human Cancer Genetics Program

External person

Anupriya Agarwal

  • Oregon Health and Science University
  • Division of Hematology and Medical Oncology

External person

Mei Jie Zhang

  • Medical College of Wisconsin
  • Department of Biostatistics
  • Center for International Blood and Marrow Transplant Research

External person

Andrew Daly

  • Alberta Health Services

External person

Michael A. Caligiuri

  • Ohio State Comprehensive Cancer Center
  • Ohio State University
  • Department of Internal Medicine, Division of Hematology, Ohio State University
  • Department of Molecular Virology, Immunology and Medical Genetics
  • Division of Human Cancer Genetics

External person

Farshid Dayyani

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Bedia A. Barkoh

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center

External person

M. Nguyen

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas at Austin

External person

Jovitta Jacob

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Elizabeth Burton

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Tai Sung Lee

  • University of Minnesota Twin Cities

External person

Concepción Boqué

  • University of Barcelona
  • Hospital Durán i Reynals

External person

Kathy Bochinski

  • University of Texas MD Anderson Cancer Center
  • Novartis Pharmaceuticals
  • Univeristate Heidelberg
  • Novartis
  • Department of Leukemia

External person

Rui Yu Wang

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Maria Florencia Tanaka

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Hematology and Oncology
  • Baylor College of Medicine
  • University of Texas Health Science Center at Houston

External person

Karine Harutyunyan

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Anna R. Franklin

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

M. Breccia

  • University of Rome La Sapienza

External person

Kimmo Porkka

  • University of Helsinki

External person

S. D. Baker

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Ohio State University
  • University of Texas Health Science Center at Houston

External person

Charles S. Cleeland

  • University of Texas MD Anderson Cancer Center

External person

Mihaela Munteanu

  • Teva Branded Pharmaceutical Products RandD
  • Clinical Development

External person

James D. Cox

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

J. Halter

  • University of Basel

External person

Vazganush Gharibyan

  • University of Texas MD Anderson Cancer Center

External person

Megan Othus

  • Southwest Oncology Group Statistical Center
  • Fred Hutchinson Cancer Research Center
  • Clinical Research Division
  • SWOG Statistical Center
  • University of Washington

External person

Gert J. Ossenkoppele

  • Vrije Universiteit Amsterdam
  • University of Amsterdam

External person

Ian W. Flinn

  • Sarah Cannon Research Institute
  • Sarah Cannon Research Institute

External person

Sergernne York

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Akihiko Kuniyasu

  • Department of Molecular Cell Function
  • University of Texas MD Anderson Cancer Center
  • Kumamoto University
  • Sojo University

External person

Richard Olsson

  • Karolinska Institutet
  • Uppsala University

External person

Aaron Gerds

  • Cleveland Clinic Foundation

External person

Xi Zhang

  • Quest Diagnostics Incorporated

External person

X. Lu

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Meetu Agrawal

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Jan Davis

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Israel Bendit

  • Universidade de São Paulo

External person

Benjamin Lichtiger

  • University of Texas MD Anderson Cancer Center
  • Department of Laboratory Medicine
  • University of Texas Health Science Center at Houston

External person

Eric Davis

  • National Institutes of Health
  • Metabolism Branch
  • University of Texas MD Anderson Cancer Center
  • Department of Lymphoma and Myeloma
  • University of Texas Health Science Center at Houston

External person

Carlo M. Croce

  • Thomas Jefferson University
  • Division of Human Cancer Genetics
  • Department of Molecular Virology, Immunology and Medical Genetics
  • Ohio State University
  • Human Cancer Genetics Program

External person

Ayman Saad

  • University of Alabama at Birmingham
  • Department of Medicine, University of Alabama at Birmingham
  • Ohio State University

External person

Henrik Hjorth-Hansen

  • Norwegian University of Science and Technology

External person

Peng Qiu

  • Department of Biomedical Engineering
  • Georgia Institute of Technology
  • University of Texas MD Anderson Cancer Center
  • MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Eric Masson

  • Novartis Pharmaceuticals Corporation
  • Novartis

External person

Rongqing Pan

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Hesham M. Amin

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Loretta A. Williams

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Elza Lomaia

  • Russian Ministry of Health

External person

Siddhartha Ganguly

  • University of Kansas

External person

Wei Gang Tong

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Stephen J. Forman

  • City of Hope National Med Center

External person

John C. Byrd

  • Department of Internal Medicine, Division of Hematology, Ohio State University
  • Ohio State University
  • Division of Hematology
  • Department of Molecular Virology, Immunology and Medical Genetics

External person

Y. F. Hui

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Roland L. Bassett

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Brian A. Jonas

  • University of California at Davis

External person

Don L. Gibbons

  • University of Texas MD Anderson Cancer Center

External person

Koen M. van Besien

  • Cornell University
  • Department of Medicine

External person

Florian H. Heidel

  • Otto von Guericke University Magdeburg
  • Friedrich Schiller University Jena
  • Johannes Gutenberg University Mainz

External person

Kevin R. Coombes

  • Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person